SlideShare a Scribd company logo
1 of 11
Viral Gene Therapy
Presented by Alex Bunk
What It Is
 Viral Gene therapy is the methodic use of viruses that
  normally cause illness as vectors to transfer genes that will
  produce desired effects in patients afflicted with certain
  illnesses.
What It Is
There is a lack of an efficient non-toxic delivery system to provide the
 successful application of gene therapy for treatment of a range of
 diseases has been a major barrier to gene therapy.

Viruses have evolved to deliver their genes to target cells and are
  considered to be the most effective means of gene delivery and have
  an ability to be manipulated to express therapeutic genes or to replicate
  specifically in certain cells. Gene therapy is being developed for a range
  of diseases including inherited monogenic disorders and cardiovascular
  disease, but it is in the treatment of cancer that this approach has been
  most evident, resulting in the licensing of a gene therapy for the routine
  treatment of head and neck cancer in China.
How It Works
 Viral gene therapy works by first removing the genes of a
  viral vector then replacing it with genes that will produce the
  desired effect.
What It Can Cure
 Viral gene therapy is capable of curing a multitude of
  diseases, both genetic and acquired.
 Diseases that viral gene therapy can cure include:
     Cancer
     Type 1 diabetes
     Sever combined immune deficiency
     Chronic granulomatous disorder
     Hemophilia
     Various cancers
     Neurodegenerative diseases
     Cystic fibrosis
Viral Vectors Used
 The two most commonly used vectors in the process are:
   Retroviruses
   Adenoviruses
 Other less frequently used viruses are:
     Adeno-associated viruses
     Lentiviruses
     Pox viruses
     Alphaviruses
     Herpes viruses
 These viruses all differ in how well they are able to transfer
  genes to the cells they recognize and are able to infect, and
  whether they alter the cell’s DNA temporarily or permanently
 These viruses are displayed on the following slide.
Risks
 There are a number of risk factors involved in viral gene therapy.
 Such problems include:
   Destruction of healthy cells in cancer treatment
   Cancerous mutations due to injection at incorrect locations on DNA
   Changes can be passed on to children if the reproductive cells are
    affected.
 In addition, interference from corporations that produce drugs
  for people with chronic illnesses, such as Medtronics who
  produce insulin pumps. Viral gene therapy is not supported by
  the entities that fund research because it would be the cure to
  the very diseases from which these corporations profit.
Advantages
 Viral gene therapy is capable of curing many diseases
 Providing a cost effective approach to curing Type I diabetes
  with minimal complications in comparison to a pancreas
  transplant. Using gene therapy abolishes the high risks of
  taking immunosuppressant drugs and would be assessable
  to a larger population pool. Currently, pancreas transplants
  are only available to individuals who are also eligible for a
  kidney transplant.
 Continuing to find cures for genetic diseases and possibly
  eliminating their existence
How it Contributes to Science
 Viral gene therapy helps us better understand viruses
 It can help us understand how viruses can be killed as well
  as how they infect certain cells
 If used in mass numbers, viral gene therapy has the potential
  of removing genetic disorders from the gene pool entirely
Conclusion
 Viral gene therapy, though it has its flaws, it can indeed lead
  to a better future for humanity
 To date, the therapeutic results of gene therapy have been
  minimal. This approach holds much potential, however,
  especially for treating single-gene disorders, and it is being
  actively investigated.
 I hope to one day see viral gene therapy replacing insulin
  pumps and pancreas transplants for type 1 diabetes.

More Related Content

What's hot

In-vivo Gene Therapy - Hope for a Cure
In-vivo Gene Therapy - Hope for a Cure In-vivo Gene Therapy - Hope for a Cure
In-vivo Gene Therapy - Hope for a Cure William Kelley
 
Gene therapy By, DR Ganesh Chalise,NAMS
Gene therapy By, DR Ganesh Chalise,NAMSGene therapy By, DR Ganesh Chalise,NAMS
Gene therapy By, DR Ganesh Chalise,NAMSGaneshbchalise
 
Advance gene therapy
Advance gene therapyAdvance gene therapy
Advance gene therapyMahendra G S
 
Success of gene therapy
Success of gene therapySuccess of gene therapy
Success of gene therapynitinniper
 
The Use of Gene Therapy to Treat Type 1 Diabetes Mellitus
The Use of Gene Therapy to Treat Type 1 Diabetes MellitusThe Use of Gene Therapy to Treat Type 1 Diabetes Mellitus
The Use of Gene Therapy to Treat Type 1 Diabetes Mellituslauradiaz97
 
Gene delivery and gene therapy . Gene delivery , Gene therapy .
Gene delivery and gene therapy . Gene delivery , Gene therapy . Gene delivery and gene therapy . Gene delivery , Gene therapy .
Gene delivery and gene therapy . Gene delivery , Gene therapy . VageshVerma1
 
Gene therapy presentation
Gene therapy presentationGene therapy presentation
Gene therapy presentationSmart Cell
 
Jmp gene therapy_intro
Jmp gene therapy_introJmp gene therapy_intro
Jmp gene therapy_introdchivenga
 
GENE THERAPY
GENE THERAPYGENE THERAPY
GENE THERAPYMUSKANKr
 
Gene therapy 1
Gene therapy 1Gene therapy 1
Gene therapy 1Sohil Shah
 
Basics of gene therapy
Basics of gene therapyBasics of gene therapy
Basics of gene therapyDr.reena singh
 

What's hot (20)

In-vivo Gene Therapy - Hope for a Cure
In-vivo Gene Therapy - Hope for a Cure In-vivo Gene Therapy - Hope for a Cure
In-vivo Gene Therapy - Hope for a Cure
 
Gene therapy By, DR Ganesh Chalise,NAMS
Gene therapy By, DR Ganesh Chalise,NAMSGene therapy By, DR Ganesh Chalise,NAMS
Gene therapy By, DR Ganesh Chalise,NAMS
 
gene therapy.
gene therapy.gene therapy.
gene therapy.
 
Advance gene therapy
Advance gene therapyAdvance gene therapy
Advance gene therapy
 
Success of gene therapy
Success of gene therapySuccess of gene therapy
Success of gene therapy
 
GENE THERAPHY
GENE THERAPHYGENE THERAPHY
GENE THERAPHY
 
Gene therapy teacher
Gene therapy teacherGene therapy teacher
Gene therapy teacher
 
Gene Therapy
Gene Therapy Gene Therapy
Gene Therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
The Use of Gene Therapy to Treat Type 1 Diabetes Mellitus
The Use of Gene Therapy to Treat Type 1 Diabetes MellitusThe Use of Gene Therapy to Treat Type 1 Diabetes Mellitus
The Use of Gene Therapy to Treat Type 1 Diabetes Mellitus
 
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
Advances in Gene Therapy: Eyal Grunebaum (The Hospital for Sick Children)
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene delivery and gene therapy . Gene delivery , Gene therapy .
Gene delivery and gene therapy . Gene delivery , Gene therapy . Gene delivery and gene therapy . Gene delivery , Gene therapy .
Gene delivery and gene therapy . Gene delivery , Gene therapy .
 
Gene therapy presentation
Gene therapy presentationGene therapy presentation
Gene therapy presentation
 
Jmp gene therapy_intro
Jmp gene therapy_introJmp gene therapy_intro
Jmp gene therapy_intro
 
GENE THERAPY
GENE THERAPYGENE THERAPY
GENE THERAPY
 
Gene therapy 1
Gene therapy 1Gene therapy 1
Gene therapy 1
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene therapy
Gene therapy Gene therapy
Gene therapy
 
Basics of gene therapy
Basics of gene therapyBasics of gene therapy
Basics of gene therapy
 

Viewers also liked

Viral Nanoparticle Research Conference
Viral Nanoparticle Research ConferenceViral Nanoparticle Research Conference
Viral Nanoparticle Research ConferenceNicole Rowley
 
Viral Gene Therapy ''Multiple Sclerosis'' by Farshid Mokhberi
Viral Gene Therapy ''Multiple Sclerosis''  by Farshid MokhberiViral Gene Therapy ''Multiple Sclerosis''  by Farshid Mokhberi
Viral Gene Therapy ''Multiple Sclerosis'' by Farshid MokhberiFarshid Mokhberi
 
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...IanTaylor50
 
Trojan Horse
Trojan HorseTrojan Horse
Trojan Horseeleky
 
LakePharma’s CHO-GSN Platform for Stable Cell Line Generation
LakePharma’s CHO-GSN Platform for Stable Cell Line GenerationLakePharma’s CHO-GSN Platform for Stable Cell Line Generation
LakePharma’s CHO-GSN Platform for Stable Cell Line GenerationJin Di, Ph.D.
 
viral nanoparticles
viral nanoparticlesviral nanoparticles
viral nanoparticlessaurav saha
 
Transfection Techniques - Overview and Technical Tips
Transfection Techniques - Overview and Technical TipsTransfection Techniques - Overview and Technical Tips
Transfection Techniques - Overview and Technical TipsProteintech Group
 
Oligonucleotide Therapeutics
Oligonucleotide TherapeuticsOligonucleotide Therapeutics
Oligonucleotide Therapeuticsasarode
 
2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...
2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...
2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...Oregon Wine Board
 
The Trojan Horse (Computing)
The Trojan Horse (Computing)The Trojan Horse (Computing)
The Trojan Horse (Computing)Angel Sophie
 

Viewers also liked (20)

Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene therapy
Gene therapy Gene therapy
Gene therapy
 
Viral Nanoparticle Research Conference
Viral Nanoparticle Research ConferenceViral Nanoparticle Research Conference
Viral Nanoparticle Research Conference
 
Viral Gene Therapy ''Multiple Sclerosis'' by Farshid Mokhberi
Viral Gene Therapy ''Multiple Sclerosis''  by Farshid MokhberiViral Gene Therapy ''Multiple Sclerosis''  by Farshid Mokhberi
Viral Gene Therapy ''Multiple Sclerosis'' by Farshid Mokhberi
 
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
CASSS Forum Poster - Enabling robist cloning method qualification in cell lin...
 
AVS 406 Presentation
AVS 406 PresentationAVS 406 Presentation
AVS 406 Presentation
 
Trojan Horse
Trojan HorseTrojan Horse
Trojan Horse
 
LakePharma’s CHO-GSN Platform for Stable Cell Line Generation
LakePharma’s CHO-GSN Platform for Stable Cell Line GenerationLakePharma’s CHO-GSN Platform for Stable Cell Line Generation
LakePharma’s CHO-GSN Platform for Stable Cell Line Generation
 
Aquasomes
AquasomesAquasomes
Aquasomes
 
viral nanoparticles
viral nanoparticlesviral nanoparticles
viral nanoparticles
 
Transfection Techniques - Overview and Technical Tips
Transfection Techniques - Overview and Technical TipsTransfection Techniques - Overview and Technical Tips
Transfection Techniques - Overview and Technical Tips
 
Oligonucleotide Therapeutics
Oligonucleotide TherapeuticsOligonucleotide Therapeutics
Oligonucleotide Therapeutics
 
2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...
2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...
2017 Oregon Wine Sympoisum| Dr. Vaughn Walton and Rick Hilton- Red Blotch Dis...
 
Electroporation
ElectroporationElectroporation
Electroporation
 
Advancements of medical biotechnology in gene therapy
Advancements of medical biotechnology in gene therapyAdvancements of medical biotechnology in gene therapy
Advancements of medical biotechnology in gene therapy
 
Trojan horse
Trojan horseTrojan horse
Trojan horse
 
Seminar On Trojan Horse
Seminar On Trojan HorseSeminar On Trojan Horse
Seminar On Trojan Horse
 
The Trojan Horse (Computing)
The Trojan Horse (Computing)The Trojan Horse (Computing)
The Trojan Horse (Computing)
 
Retro virus
Retro virusRetro virus
Retro virus
 
Anti viral
Anti viralAnti viral
Anti viral
 

Similar to Viral gene therapy

GENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applicationsGENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applicationshritika508
 
Nucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxNucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxPrachi Pandey
 
Nucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxNucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxRAHUL PAL
 
Nucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxNucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxPrachi Pandey
 
Gene therapy advanced treatments for a new era aranca special report
Gene therapy   advanced treatments for a new era aranca special reportGene therapy   advanced treatments for a new era aranca special report
Gene therapy advanced treatments for a new era aranca special reportAranca
 
Gene medicine by kk sahu sir
Gene medicine by kk sahu sirGene medicine by kk sahu sir
Gene medicine by kk sahu sirKAUSHAL SAHU
 
gene-therapy.pptx
gene-therapy.pptxgene-therapy.pptx
gene-therapy.pptxjacksgamer
 
Genetherapypresentation 120220051948-phpapp02
Genetherapypresentation 120220051948-phpapp02Genetherapypresentation 120220051948-phpapp02
Genetherapypresentation 120220051948-phpapp02sujinthomassm
 
Genetherapy : An Overview
Genetherapy : An OverviewGenetherapy : An Overview
Genetherapy : An OverviewV4Veeru25
 

Similar to Viral gene therapy (20)

GENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applicationsGENE THERAPY : introduction, advancements and applications
GENE THERAPY : introduction, advancements and applications
 
Nucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxNucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptx
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Nucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxNucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptx
 
Nucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptxNucleic Acid Based Therapeutic Delivery System.pptx
Nucleic Acid Based Therapeutic Delivery System.pptx
 
Gene therapy advanced treatments for a new era aranca special report
Gene therapy   advanced treatments for a new era aranca special reportGene therapy   advanced treatments for a new era aranca special report
Gene therapy advanced treatments for a new era aranca special report
 
Molecular Biology
Molecular BiologyMolecular Biology
Molecular Biology
 
Gene medicine by kk sahu sir
Gene medicine by kk sahu sirGene medicine by kk sahu sir
Gene medicine by kk sahu sir
 
Viral Vector for Gene Therapy
Viral Vector for Gene TherapyViral Vector for Gene Therapy
Viral Vector for Gene Therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Nucleic acid based therapeutic delivery system
Nucleic acid based therapeutic delivery systemNucleic acid based therapeutic delivery system
Nucleic acid based therapeutic delivery system
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
gene-therapy.pptx
gene-therapy.pptxgene-therapy.pptx
gene-therapy.pptx
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Genetherapypresentation 120220051948-phpapp02
Genetherapypresentation 120220051948-phpapp02Genetherapypresentation 120220051948-phpapp02
Genetherapypresentation 120220051948-phpapp02
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 
Genetherapy : An Overview
Genetherapy : An OverviewGenetherapy : An Overview
Genetherapy : An Overview
 
Strategies of gene therapy
Strategies of gene therapyStrategies of gene therapy
Strategies of gene therapy
 
Gene therapy
Gene therapyGene therapy
Gene therapy
 

Recently uploaded

Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKJago de Vreede
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherRemote DBA Services
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingEdi Saputra
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistandanishmna97
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxRustici Software
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century educationjfdjdjcjdnsjd
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Victor Rentea
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfsudhanshuwaghmare1
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyKhushali Kathiriya
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businesspanagenda
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FMESafe Software
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...apidays
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProduct Anonymous
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...Martijn de Jong
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 

Recently uploaded (20)

Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
Apidays New York 2024 - The Good, the Bad and the Governed by David O'Neill, ...
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 

Viral gene therapy

  • 2. What It Is  Viral Gene therapy is the methodic use of viruses that normally cause illness as vectors to transfer genes that will produce desired effects in patients afflicted with certain illnesses.
  • 3. What It Is There is a lack of an efficient non-toxic delivery system to provide the successful application of gene therapy for treatment of a range of diseases has been a major barrier to gene therapy. Viruses have evolved to deliver their genes to target cells and are considered to be the most effective means of gene delivery and have an ability to be manipulated to express therapeutic genes or to replicate specifically in certain cells. Gene therapy is being developed for a range of diseases including inherited monogenic disorders and cardiovascular disease, but it is in the treatment of cancer that this approach has been most evident, resulting in the licensing of a gene therapy for the routine treatment of head and neck cancer in China.
  • 4. How It Works  Viral gene therapy works by first removing the genes of a viral vector then replacing it with genes that will produce the desired effect.
  • 5. What It Can Cure  Viral gene therapy is capable of curing a multitude of diseases, both genetic and acquired.  Diseases that viral gene therapy can cure include:  Cancer  Type 1 diabetes  Sever combined immune deficiency  Chronic granulomatous disorder  Hemophilia  Various cancers  Neurodegenerative diseases  Cystic fibrosis
  • 6. Viral Vectors Used  The two most commonly used vectors in the process are:  Retroviruses  Adenoviruses  Other less frequently used viruses are:  Adeno-associated viruses  Lentiviruses  Pox viruses  Alphaviruses  Herpes viruses  These viruses all differ in how well they are able to transfer genes to the cells they recognize and are able to infect, and whether they alter the cell’s DNA temporarily or permanently  These viruses are displayed on the following slide.
  • 7.
  • 8. Risks  There are a number of risk factors involved in viral gene therapy.  Such problems include:  Destruction of healthy cells in cancer treatment  Cancerous mutations due to injection at incorrect locations on DNA  Changes can be passed on to children if the reproductive cells are affected.  In addition, interference from corporations that produce drugs for people with chronic illnesses, such as Medtronics who produce insulin pumps. Viral gene therapy is not supported by the entities that fund research because it would be the cure to the very diseases from which these corporations profit.
  • 9. Advantages  Viral gene therapy is capable of curing many diseases  Providing a cost effective approach to curing Type I diabetes with minimal complications in comparison to a pancreas transplant. Using gene therapy abolishes the high risks of taking immunosuppressant drugs and would be assessable to a larger population pool. Currently, pancreas transplants are only available to individuals who are also eligible for a kidney transplant.  Continuing to find cures for genetic diseases and possibly eliminating their existence
  • 10. How it Contributes to Science  Viral gene therapy helps us better understand viruses  It can help us understand how viruses can be killed as well as how they infect certain cells  If used in mass numbers, viral gene therapy has the potential of removing genetic disorders from the gene pool entirely
  • 11. Conclusion  Viral gene therapy, though it has its flaws, it can indeed lead to a better future for humanity  To date, the therapeutic results of gene therapy have been minimal. This approach holds much potential, however, especially for treating single-gene disorders, and it is being actively investigated.  I hope to one day see viral gene therapy replacing insulin pumps and pancreas transplants for type 1 diabetes.